Pharmaceutical Headlines for April 27 2012 ( Friday )


• Novo Nordisk A/S (NVO) to Boost US Workforce by 15 Percent More...

• Imprimis Pharmaceuticals Closes $7.95 Million Financing and Provides Progress Report to Shareholders More...

• Jazz Pharmaceuticals, Inc. (JAZZ) Buying EUSA Pharma for Up to $700 Million More...

• Renhe Pharmacy Pays $46 Million for Two Pharma Acquisitions More...

• Allenex AB Sells Its Holding in Pharmacolog More...

• VWR International, Inc. Signs Agreement to Acquire basan Germany GmbH More...

• FAES Farma and Invida (a Menarini Group Company) Announce Agreement to Commercialize Bilastine in 17 Markets in Asia - Pacific More...

• Somaxon Pharmaceuticals, Inc. (SOMX) and CJ CheilJedang Announce Silenor® Collaboration in South Korea More...

• Array BioPharma, Inc. (ARRY) Names Ron Squarer Chief Executive Officer More...

• Trinean nv Appoints New CEO and Secures 2.7 Million Euro Financing More...

• PDL BioPharma, Inc. (PDLI) Appoints Bruce Tomlinsonas Chief Financial Officer More...

• Ms. Julia R. Brown and Mr. Davey S. Scoon Join Biodel Inc. (BIOD) Board of Directors More...

• Lota S. Zoth Joins Orexigen Therapeutics, Inc. (OREX) Board of Directors More...

• Alnylam Pharmaceuticals (ALNY) to Webcast Conference Call Discussing First Quarter 2012 Financial Results More...

• Accelrys Inc. (ACCL) to Announce First Quarter 2012 Results on May 3, 2012 More...

• First Quarter 2012/Annual Meeting: BASF With Solid Start to the Year More...

• BioMarin Pharmaceutical Inc. (BMRN) Announces First Quarter 2012 Financial Results More...

• BioScrip (BIOS) to Host First Quarter 2012 Earnings Call More...

• Could Bristol-Myers Squibb Company (BMY) be a Target of Bribery? More...

• Sucampo Pharmaceuticals, Inc. Provides Update on Anticipated Arbitration Decision Date More...

• FDA Rejects Amgen (AMGN)'s BLA for Xgeva More...

• Dynavax Technologies Corporation (DVAX) Reports HEPLISAV™ BLA Submission More...

• GlaxoSmithKline (GSK) and Genmab A/S (GEN.CO) Release: New Drug Application for Arzerra Submitted in Japan More...

• FDA Warns Not to Mix Merck & Co., Inc. (MRK) Hep C Drug With HIV Meds More...

• FDA Approves Novartis AG (NVS)'s Afinitor for Kidney Tumors More...

• FDA Approves GlaxoSmithKline (GSK)'s Votrient® for Deadly Sarcomas More...

• Results From Chelsea Therapeutics, Inc. (CHTP)' Pivotal Northera™ (Droxidopa) Study to be Presented at the American Academy of Neurology's Annual Meeting More...

• Baxter International, Inc. (BAX) Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at American Academy of Neurology Annual Meeting More...

• UCB, Inc. (UCBJF.PK) Release: Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology More...

• New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) (BIIB) & Biogen Idec, Inc. (Massachusetts) (BIIB) Commitment to Improving Outcomes in Multiple Sclerosis More...

• Building Muscle Without Heavy Weights, McMaster University Study More...

• Analytic Thinking Can Decrease Religious Belief, University of British Columbia Study More...

• Women Who Smoke in Pregnancy More Likely to Have Child With High Functioning Autism, University of Wisconsin Study More...

• High Salt Intake Linked to Higher Stroke Risk, University of Warwick Study More...

• Breast Cancer Link With Diet, Karolinska Institute Study More...

• Ampio Pharmaceuticals, Inc. (AMPE) Awarded US and Canadian Patents That Will Bolster the Commercialization of Optina™ for the Treatment of Diabetic Macular Edema (DME) More...

• Ranbaxy Laboratories (RANBAXY.BO) Creates India's First New Drug More...

• Pharmaxis Ltd (PXS.AX) Receives Approval to Market Bronchitol in the EU More...

• GlaxoSmithKline (GSK) Attacks National Institute for Clinical Excellence (NICE) for Rejecting New Lupus Treatment More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply